Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis	Recruiting	Phase 3	2025-02-10		NCT04975178

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Biofabri, S.L	2
Biomedical Research Center EPLS	1
Institut Pasteur de Madagascar	3
TuBerculosis Vaccine Initiative	1
Universidad de Zaragoza	26
University of Cape Town	47
University of KwaZulu	10
University of Stellenbosch	31
Wits Health Consortium (Pty) Ltd	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
South African Tuberculosis Initiative, Brewelskloof Hospital	Worcester	South Africa	1